• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 3. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 4. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 5. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Tryptamines and derivatives

Professional Introduction to Compound with CAS No. 187085-81-0 and Product Name: 1H-Indole-3-propanamide, α-amino-N-(phenylmethyl)

The compound with the CAS number 187085-81-0 and the product name 1H-Indole-3-propanamide, α-amino-N-(phenylmethyl) represents a significant advancement in the field of pharmaceutical chemistry and medicinal biology. This compound, characterized by its unique structural framework, has garnered considerable attention due to its potential applications in drug discovery and therapeutic development. The indole core, a well-documented pharmacophore in medicinal chemistry, is combined with an amide functional group and an N-substituted benzyl moiety, which collectively contribute to its diverse biological activities.

Recent studies have highlighted the importance of indole derivatives in the development of novel therapeutic agents. The indole ring system is known for its presence in numerous bioactive molecules, including natural products and synthetic drugs. The structural motif of 1H-Indole-3-propanamide, α-amino-N-(phenylmethyl) not only inherits the inherent properties of indole but also introduces additional functional groups that can modulate its pharmacological profile. This compound has been extensively investigated for its potential role in modulating various biological pathways, particularly those involving inflammation, neurodegeneration, and cancer.

In the realm of oncology research, the compound has shown promising results in preclinical studies. The amide linkage and the N-benzyl substitution are strategically positioned to interact with biological targets such as kinases and transcription factors. These interactions are crucial for inhibiting the proliferation of cancer cells and inducing apoptosis. Specifically, the benzylamino group has been found to enhance binding affinity to certain protein targets, making it a valuable scaffold for further derivatization and optimization.

Moreover, the compound exhibits significant anti-inflammatory properties. Chronic inflammation is a hallmark of many diseases, including autoimmune disorders and metabolic syndromes. The indole core has been shown to interact with nuclear receptors such as peroxisome proliferator-activated receptors (PPARs), which play a critical role in regulating inflammatory responses. The presence of an amide group in 1H-Indole-3-propanamide, α-amino-N-(phenylmethyl) facilitates its interaction with these receptors, leading to downregulation of pro-inflammatory cytokines and reduction in inflammatory cell recruitment.

Neurodegenerative diseases represent another area where this compound shows immense promise. Parkinson's disease and Alzheimer's disease are two prevalent neurodegenerative disorders characterized by the aggregation of misfolded proteins and oxidative stress. Studies indicate that indole derivatives can modulate enzymatic activity and prevent the formation of toxic protein aggregates. The structural features of 1H-Indole-3-propanamide, α-amino-N-(phenylmethyl) make it a potential candidate for inhibiting enzymes such as monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT), which are implicated in the pathogenesis of these diseases.

The synthesis of this compound involves a multi-step process that requires precise control over reaction conditions to ensure high yield and purity. The key steps include condensation reactions between indole derivatives and propanoic acid derivatives, followed by N-benzyl protection using benzyl chloroformate or benzyl bromide. Advanced spectroscopic techniques such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS) are employed to confirm the structural integrity of the final product.

From a computational chemistry perspective, molecular modeling studies have been instrumental in understanding the binding interactions of 1H-Indole-3-propanamide, α-amino-N-(phenylmethyl) with biological targets. These studies have provided insights into the optimal conformational arrangement required for maximal binding affinity. Additionally, computational methods have been used to predict potential drug-likeness properties such as solubility, permeability, and metabolic stability, which are critical factors in determining the feasibility of clinical translation.

The pharmacokinetic profile of this compound is another area of active investigation. Understanding how a drug is absorbed, distributed, metabolized, and excreted (ADME) is essential for optimizing therapeutic efficacy and minimizing side effects. Preliminary pharmacokinetic studies suggest that 1H-Indole-3-propanamide, α-amino-N-(phenylmethyl) exhibits favorable absorption characteristics when administered orally. However, further studies are needed to assess its metabolic stability and excretion pathways.

In conclusion,1H-Indole-3-propanamide, α-amino-N-(phenylmethyl) represents a promising lead compound with significant potential in multiple therapeutic areas. Its unique structural features make it an attractive scaffold for further derivatization and optimization aimed at improving pharmacological activity and safety profiles. Continued research efforts are warranted to explore its full therapeutic potential and translate these findings into clinical applications.

• 158861-67-7(Pralmorelin Diacetate Salt)
• 164991-89-3(Segetalin B)
• 2382-79-8(N-alpha-Acetyl-L-tryptophan amide)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)